Consolidated Condensed Statements of Stockholders Deficit (Unaudited) - USD ($) $ in Millions	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)
Balance (in shares) at Oct. 31, 2021		1,092,205,000
Balance at beginning of period at Oct. 31, 2021	$ (1,650)	$ 11	$ 1,060	$ (2,461)	$ (260)
Increase (Decrease) in Stockholders' Equity
Net earnings	2,086			2,086
Other comprehensive income, net of taxes	607				607
Comprehensive income	2,693
Issuance of common stock in connection with employee stock plans and other (in shares)		10,384,000
Issuance of common stock in connection with employee stock plans and other	$ (113)		(113)
Repurchases of common stock (in shares)	(69,000,000)	(69,197,000)
Repurchases of common stock (Note 10)	$ (2,498)	$ (1)	(69)	(2,428)
Cash dividends	(533)			(533)
Stock-based compensation expense	203		203
Balance (in shares) at Apr. 30, 2022		1,033,392,000
Balance at end of period at Apr. 30, 2022	(1,898)	$ 10	1,081	(3,336)	347
Balance (in shares) at Jan. 31, 2022		1,059,900,000
Balance at beginning of period at Jan. 31, 2022	(2,328)	$ 11	1,046	(3,369)	(16)
Increase (Decrease) in Stockholders' Equity
Net earnings	1,000			1,000
Other comprehensive income, net of taxes	363				363
Comprehensive income	1,363
Issuance of common stock in connection with employee stock plans and other (in shares)		608,000
Issuance of common stock in connection with employee stock plans and other	$ (7)		(7)
Repurchases of common stock (in shares)	(27,000,000)	(27,116,000)
Repurchases of common stock (Note 10)	$ (999)	$ (1)	(28)	(970)
Cash dividends	3			3
Stock-based compensation expense	70		70
Balance (in shares) at Apr. 30, 2022		1,033,392,000
Balance at end of period at Apr. 30, 2022	$ (1,898)	$ 10	1,081	(3,336)	347
Balance (in shares) at Oct. 31, 2022	980,000,000	979,869,000
Balance at beginning of period at Oct. 31, 2022	$ (2,918)	$ 10	1,172	(4,413)	313
Increase (Decrease) in Stockholders' Equity
Net earnings	1,553			1,553
Other comprehensive income, net of taxes	(681)				(681)
Comprehensive income	872
Issuance of common stock in connection with employee stock plans and other (in shares)		9,631,000
Issuance of common stock in connection with employee stock plans and other	$ (86)		(86)
Repurchases of common stock (in shares)	(3,600,000)	(3,624,000)
Repurchases of common stock (Note 10)	$ (100)		(4)	(96)
Cash dividends	(514)			(514)
Stock-based compensation expense	$ 262		262
Balance (in shares) at Apr. 30, 2023	986,000,000	985,876,000
Balance at end of period at Apr. 30, 2023	$ (2,484)	$ 10	1,344	(3,470)	(368)
Balance (in shares) at Jan. 31, 2023		985,089,000
Balance at beginning of period at Jan. 31, 2023	(3,730)	$ 10	1,256	(4,540)	(456)
Increase (Decrease) in Stockholders' Equity
Net earnings	1,066			1,066
Other comprehensive income, net of taxes	88				88
Comprehensive income	1,154
Issuance of common stock in connection with employee stock plans and other (in shares)		787,000
Issuance of common stock in connection with employee stock plans and other	$ (7)		(7)
Repurchases of common stock (in shares)	0
Cash dividends	$ 4			4
Stock-based compensation expense	$ 95		95
Balance (in shares) at Apr. 30, 2023	986,000,000	985,876,000
Balance at end of period at Apr. 30, 2023	$ (2,484)	$ 10	$ 1,344	$ (3,470)	$ (368)